Nocistatin and its derivatives antagonize the impairment of short-term acquisition induced by nociceptin

Neuroscience Letters

Volumn 416, Issue 2, 2007, Pages 155-159

  Liu, Eugene Hern C ^a   Lee, Tat Leang ^a   Nishiuchi, Yuji ^b   Kimura, Terutoshi ^b   Tachibana, Shinro ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b Peptide Institute Inc   (Japan)

Author keywords

Nociceptin orphanin FQ; Nocistatin; Passive avoidance

Indexed keywords

NOCICEPTIN; NOCICEPTIN 1; NOCISTATIN; NOCISTATIN 17; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; AVOIDANCE BEHAVIOR; CONTROLLED STUDY; LEARNING; MALE; MEMORY; MOUSE; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL;

ANIMALS; AVOIDANCE LEARNING; BRAIN; HUMANS; MALE; MEMORY; MICE; OPIOID PEPTIDES; RECEPTORS, OPIOID;

EID: 33947326581     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2007.01.066     Document Type: Article

References (18)

1. Berger H., Calo' G., Albrecht E., Guerrini R., and Bienert M. [Nphe(1)]NC(1-13)NH(2) selectively antagonizes nociceptin/orphanin FQ-stimulated G-protein activation in rat brain. J. Pharmacol. Exp. Ther. 294 (2000) 428-433
2. Carpenter K.J., and Dickenson A.H. Evidence that [Phe1 psi(CH2-NH)Gly2]nociceptin-(1-13)-NH2, a peripheral ORL-1 receptor antagonist, acts as an agonist in the rat spinal cord. Br. J. Pharmacol. 125 (1998) 949-951
3. Elrod K., and Buccafusco J.J. An evaluation of the mechanism of scopolamine-induced impairment in two passive avoidance protocols. Pharmacol. Biochem. Behav. 29 (1988) 15-21
4. Gavioli E.C., Rae G.A., Calo' G., Guerrini R., and De Lima T.C. Central injections of nocistatin or its C-terminal hexapeptide exert anxiogenic-like effect on behaviour of mice in the plus-maze test. Br. J. Pharmacol. 136 (2002) 764-772
5. Haley T.J., and McCormick W.G. Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. Br. J. Pharmacol. 12 (1957) 12-15
6. Hiramatsu M., and Inoue K. Effects of nocistatin on nociceptin-induced impairment of learning and memory in mice. Eur. J. Pharmacol. 367 (1999) 151-155
7. Hiramatsu M., and Inoue K. Nociceptin/orphanin FQ and nocistatin on learning and memory impairment induced by scopolamine in mice. Br. J. Pharmacol. 127 (1999) 655-660
8. Joseph T., Lee T.L., Ning C., Nishiuchi Y., Kimura T., Jikuya H., Ou K., Chin Y.C., and Tachibana S. Identification of mature nocistatin and nociceptin in human brain and cerebrospinal fluid by mass spectrometry combined with affinity chromatography and HPLC. Peptides 27 (2006) 122-130
9. Liu E.H., Nishiuchi Y., Kimura T., and Tachibana S. Supraspinal nocistatin and its amide derivative antagonize the hyperalgesic effects of nociceptin in mice. Neurosci. Lett. 397 (2006) 59-63
10. Mamiya T., Noda Y., Nishi M., Takeshima H., and Nabeshima T. Enhancement of spatial attention in nociceptin/orphanin FQ receptor-knockout mice. Brain Res. 783 (1998) 236-240
11. Manabe T., Noda Y., Mamiya T., Katagiri H., Houtani T., Nishi M., Noda T., Takahashi T., Sugimoto T., Nabeshima T., and Takeshima H. Facilitation of long-term potentiation and memory in mice lacking nociceptin receptors. Nature 394 (1998) 577-581
12. Meunier J.C., and Nociceptin/orphanin. FQ and the opioid receptor-like ORL1 receptor. Eur. J. Pharmacol. 340 (1997) 1-15
13. Meunier J.C., Mollereau C., Toll L., Suaudeau C., Moisand C., Alvinerie P., Butour J.L., Guillemot J.C., Ferrara P., Monsarrat B., Mazarguil B., Vassart G., Parmentier M., and Costentin J. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature 377 (1995) 532-535
14. Nakagawa T., Kaneko M., Inamura S., and Satoh M. Intracerebroventricular administration of nocistatin reduces inflammatory hyperalgesia in rats. Neurosci. Lett. 265 (1999) 64-66
15. Noda Y., Mamiya T., Manabe T., Nishi M., Takeshima H., and Nabeshima T. Role of nociceptin systems in learning and memory. Peptides 21 (2000) 1063-1069
16. Okuda-Ashitaka E., Minami T., Tachibana S., Yoshihara Y., Nishiuchi Y., Kimura T., and Ito S. Nocistatin a peptide that blocks nociceptin action in pain transmission. Nature 392 (1998) 286-289
17. Reinscheid R.K., Nothacker H.P., Bourson A., Ardati A., Henningsen R.A., Bunzow J.R., Grandy D.K., Langen H., Monsma Jr. F.J., and Civelli O. Orphanin FQ: a neuropeptide that activates an opioidlike G protein-coupled receptor. Science 270 (1995) 792-794
18. Scoto G.M., Santangelo N., and Parenti C. Effect of supraspinal nocistatin on nociceptin/orphanin FQ antagonism of selective opioid analgesia. Neurosci. Lett. 387 (2005) 126-129